Searched over 200M research papers
10 papers analyzed
Some studies suggest that radiation therapy can cause significant long-term and early side effects, including cognitive impairments and severe acute tissue reactions, while other studies highlight technological advances and new strategies that may reduce toxicity and improve quality of life.
20 papers analyzed
Radiation therapy (RT) is a cornerstone in the treatment of various cancers, but it is accompanied by a range of side effects that can significantly impact patients' quality of life. These side effects can be categorized into early (acute) and late (chronic) effects, each with distinct characteristics and management strategies.
Patients undergoing radiation therapy for head and neck cancer often experience immediate side effects such as mucositis (inflammation of the oropharyngeal mucosa), odynophagia (painful swallowing), dysphagia (difficulty swallowing), xerostomia (lack of saliva), orofacial pain, laryngeal radionecrosis, dermatitis, hair loss, nausea, vomiting, inadequate nutrition and hydration, and weight loss . These complications can interfere with and delay treatment, but they generally dissipate over time with appropriate management.
Early side effects are often dose-limiting factors in radiotherapy. Acute normal tissue reactions, such as those in the upper aerodigestive tract, can become severe with altered fractionation schedules like hyperfractionation and accelerated fractionation, especially when combined with chemotherapy. Effective measures to ameliorate these side effects are essential for the further development of cancer therapy.
Late side effects of radiation therapy for head and neck cancer include permanent loss of saliva, osteoradionecrosis, radiation recall myositis, pharyngoesophageal stenosis, dental caries, oral cavity necrosis, fibrosis, impaired wound healing, skin changes and skin cancer, lymphedema, hypothyroidism, hyperparathyroidism, lightheadedness, dizziness, headaches, secondary cancer, and damage to eye, ear, neurological, and neck structures. These side effects present significant challenges and require lifelong management strategies to mitigate their impact on basic life functions and quality of life.
Radiotherapy for brain tumors can lead to progressive and debilitating cognitive impairments, affecting learning, memory, processing speed, attention, and executive functions. Neuroinflammation is considered a major mechanism responsible for these cognitive deficits and neurotoxicity.
Technological advances in radiotherapy have improved the precision of radiation delivery, thereby reducing the exposure of surrounding normal tissues and minimizing side effects. However, understanding the molecular and physiological mechanisms of normal tissue responses to radiotherapy is crucial for further reducing these side effects and optimizing treatment delivery .
The combination of radiotherapy with chemotherapy or targeted drugs can lead to specific toxicities or negatively influence the efficacy of RT. Clinical trials are needed to address the open questions regarding the efficacy and toxicity of these combined treatments.
Mesenchymal stem cells (MSCs) have shown promise in mitigating radiotherapy side effects due to their capabilities in mesodermal differentiation, immunomodulation, and paracrine secretion. Current research is focused on exploring the potential of MSCs in clinical care to alleviate radiation-induced injuries.
Radiation therapy, while effective in treating various cancers, is associated with a range of early and late side effects that can significantly impact patients' quality of life. Advances in technology and a better understanding of the underlying mechanisms of these side effects are essential for improving patient outcomes. Ongoing research into combined treatments and innovative therapies like stem cell-based interventions holds promise for mitigating the adverse effects of radiotherapy.
Most relevant research papers on this topic